Senseonics Holdings (SENS) closed at $10.42 on November 11, 2026, up 3.9% from the previous close, on volume of 1,288,958 shares (30-day average 757,906).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Senseonics hits 52-week high as Raymond James upgrades on Q3 beat and raise
Seeking Alpha News (Tue, 10-Nov 10:33 AM ET)
TD Cowen Sticks to Its Buy Rating for Senseonics Holdings (SENS)
TipRanks (Tue, 10-Nov 7:55 AM ET)
Senseonics’ Accelerating Commercial Momentum Supports Buy Rating; $14 Price Target Maintained
TipRanks (Tue, 10-Nov 7:26 AM ET)
Senseonics GAAP EPS of -$0.50 beats by $0.02, revenue of $19.6M beats by $3.4M
Seeking Alpha News (Mon, 9-Nov 4:25 PM ET)
Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results
Globe Newswire (Mon, 9-Nov 4:05 PM ET)
Earnings Week Ahead: CSCO, CRWV, PLUG, ALC, AMAT, ACB, RKLB, ASTS, and more
Seeking Alpha News (Sun, 8-Nov 8:07 AM ET)
Globe Newswire (Mon, 26-Oct 8:00 AM ET)
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
Globe Newswire (Thu, 22-Oct 8:00 AM ET)
Globe Newswire (Wed, 21-Oct 8:00 AM ET)
Globe Newswire (Mon, 14-Sep 7:00 AM ET)
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
Senseonics Holdings trades on the NASDAQ stock market under the symbol SENS.
As of November 11, 2026, SENS stock price climbed to $10.42 with 1,288,958 million shares trading.
SENS has a beta of 2.48, meaning it tends to be more sensitive to market movements. SENS has a correlation of 0.12 to the broad based SPY ETF.
SENS has a market cap of $570.81 million. This is considered a Small Cap stock.
Last quarter Senseonics Holdings reported $20 million in Revenue and -$.50 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.02.
In the last 3 years, SENS traded as high as $28.00 and as low as $4.79.
The top ETF exchange traded funds that SENS belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.
SENS has outperformed the market in the last year with a price return of +64.6% while the SPY ETF gained +12.6%. SENS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +38.2% and +25.1%, respectively, while the SPY returned -1.5% and -1.3%, respectively.
SENS support price is $9.46 and resistance is $10.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SENS shares will trade within this expected range on the day.
